Complementary Treatment Options

The most essentially needed are:

• Advanced Eye and Vision Support Formula (Dr. Grossman’s Formula) for supporting retina and general ocular health.
• Vitamin A Palmitate (capsular form with 15,000 IU each).
• Omega-3 Fish Oil (Carlsons).
• MCS 100ile buy choice – aids in stimulating retinal energy production, enhancing blood supply and reducing unnecessary waste from building up.
• CoQ-10 Capsules or COQ26 – this is an enzyme present all through the cells in the body occurring innately and co-factoring the electron transporting link in-between cells.
• Acetyl-L-Carnitine capsular form.
• Sublingual Pure Focus formulation for eye health.
• Supplements with organic formulations rich in fruit, veggie and herbal constituents.

Recommendations of Vitamin, Supplement, Herb and other Dietetic Items

As eye disorders are partly deemed manifestations of overall body health, hence making changes in one’s lifestyle and dietetic intake could be key contributing factors to get and maintain normal vision.

• Reducing or eliminating consumption of caffeine and aerated drinks (soda), avoiding aspartame and synthetic fats (oils like hydrogenated vegetable, corn, safflower, trans fats and particularly margarine).
• Eliminating deeply fried food items, MSG or monosodium glutamate that are savour enhancing agents having potentially toxic effect on the retina and fat blocking agents such as Olestra that impedes carotenoid absorption. Consuming larger quantities of saturated fats and cholesterol-raising foods seem to raise chances of developing AMD or age-related macular degeneration.
• Supplementing diet with a multivitamin intake daily and even consuming organic green tea would be beneficial.

Update on Conventional Treatment Choices

Exhaustive on-going studies are being carried out for finding the reasons, treatments for all types of RP. Investigators have uncovered several heritable variants leading Usher syndrome facilitating for description of a host of sub-forms 1A to 1F, 2A to 2C and 3A.

A second or third phase human clinical testing is in progress for testing ECT or encapsulated cell technology for delivering of eyesight-conserving, remedial agent CNTF or ciliary neurotrophic factor to the retinal area. Introductory outcomes from the first phase study of ECT and CNTF have been immensely heartening.

Additionally investigators have carried out experiments using synthetic retinal implants which are contrivances whose placement is done on the retinal surface for restoring basic, purposeful vision.

Positive progress been made by investigators in the field of gene therapy for treating Usher syndrome wherein delivery of normal gene is done to the retina for replacing the ailment-causative gene that has undergone mutation. Gene therapy could additionally be employed for treatment of auditory loss.

During clinical studies done for gene therapy in case of acute type of RP called as Leber congenital amaurosis, there was some extent of eyesight restoration among younger adults that had almost lost their eyesight.

Retinal cell transplantation is one more field of increasing interest wherein transplantation of retinal cells would reinstate retinal cells that were damaged due to RP and other degenerative retina ailments.